6-K
File 001-15170
US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B
- Filing date
- 21 Oct 2026
- Reporting date
- 21 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,846 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 1-25 of 1,000 matching filings.
Per page
25
Current page
1
6-K
File 001-15170
JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER
- Filing date
- 19 Oct 2026
- Reporting date
- 19 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
RIS-REZ POSITIVE EARLY DATA IN LUNG CANCER
- Filing date
- 19 Oct 2026
- Reporting date
- 19 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 15 Oct 2026
- Reporting date
- 15 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 14 Oct 2026
- Reporting date
- 14 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
S-8
File 333-299423
S-8
- Filing date
- 13 Oct 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Oct 2026
- Reporting date
- 13 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Oct 2026
- Reporting date
- 13 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
WENDY BECKER CBE - NEW DIRECTORSHIP
- Filing date
- 08 Oct 2026
- Reporting date
- 08 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
ADMISSION TO TRADING
- Filing date
- 06 Oct 2026
- Reporting date
- 06 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Oct 2026
- Reporting date
- 01 Oct 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 24 Sep 2026
- Reporting date
- 24 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
CERT
File 001-15170
NYSE CERTIFICATION
- Filing date
- 22 Sep 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 22 Sep 2026
- Reporting date
- 22 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-A12B
File 001-15170
8-A12B
- Filing date
- 15 Sep 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
6-K
- Filing date
- 15 Sep 2026
- Reporting date
- 15 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK TO ACQUIRE T CELL-ENGAGER FOR MULTIPLE MYELOMA
- Filing date
- 15 Sep 2026
- Reporting date
- 15 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
RIS-REZ POSITIVE PH 3 OS LUNG CANCER DATA IN CHINA
- Filing date
- 14 Sep 2026
- Reporting date
- 14 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
JIDEYTRO POSITIVE DATA FOR ROS1-POSITIVE NSCLC
- Filing date
- 14 Sep 2026
- Reporting date
- 14 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 11 Sep 2026
- Reporting date
- 11 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 10 Sep 2026
- Reporting date
- 10 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
424B2
File 333-278205
424B2
- Filing date
- 10 Sep 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
6-K
File 001-15170
JAPAN APPROVAL OF SHINGRIX IN A PREFILLED SYRINGE
- Filing date
- 10 Sep 2026
- Reporting date
- 10 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 09 Sep 2026
- Reporting date
- 09 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 09 Sep 2026
- Reporting date
- 09 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing